Atea Pharmaceuticals, Inc. (AVIR)

Atea Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	160.91	143.82	188.66	764.68	850.12	21.66
Short-Term Investments	380.58	434.28	458.25	0	0	0
Cash & Cash Equivalents	541.49	578.11	646.91	764.68	850.12	21.66
Cash Growth	-12.76%	-10.64%	-15.40%	-10.05%	3824.64%	-37.20%
Receivables	0	0	0	0	5.82	0
Other Current Assets	7.27	12.35	14.02	7.72	7.55	0.25
Total Current Assets	548.76	590.46	660.92	772.4	863.48	21.91
Property, Plant & Equipment	2.87	3.12	4.09	0.18	0.05	0.04
Other Long-Term Assets	1.4	1.4	1.69	0.31	0.11	0.12
Total Long-Term Assets	4.27	4.51	5.79	0.49	0.16	0.16
Total Assets	553.03	594.97	666.71	772.89	863.63	22.07
Accounts Payable	21.14	4.25	2.55	4.53	0.06	0.55
Deferred Revenue	0	0	0	0	301.37	0
Current Debt	0.77	0.76	0.72	0.2	0	0
Other Current Liabilities	19.41	27.36	15.21	52.15	14.37	1.89
Total Current Liabilities	41.31	32.38	18.48	56.88	315.8	2.44
Long-Term Debt	1.45	1.64	2.4	0	0	0
Other Long-Term Liabilities	5.9	5.76	5.26	5.93	0.04	0.1
Total Long-Term Liabilities	7.35	7.4	7.66	5.93	0.04	0.1
Total Liabilities	48.66	39.78	26.14	62.82	315.83	2.53
Total Debt	2.21	2.4	3.12	0.2	0	0
Debt Growth	-24.82%	-23.11%	1485.79%	-	-	-
Retained Earnings	-259	-195.84	-59.88	56.03	-65.16	-54.21
Comprehensive Income	-0.18	0.21	-0.68	0	0	0
Shareholders' Equity	504.37	555.19	640.57	710.08	547.8	-49.57
Net Cash / Debt	539.28	575.7	643.78	764.48	850.12	21.66
Net Cash / Debt Growth	-12.70%	-10.57%	-15.79%	-10.07%	3824.64%	-37.20%
Net Cash Per Share	6.43	6.90	7.73	8.66	39.37	2.15
Working Capital	507.45	558.08	642.44	715.52	547.68	19.48
Book Value Per Share	6.01	6.66	7.70	8.57	25.37	-4.91

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).